Sign inJoin waitlistJoin the waitlist

TB

Tymara Berry

Pediatrics / Pediatric Endocrinology

Credentials: · ·

Research

Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure
American Journal of Hematology · 2020 · 136 citations
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised,…
The Lancet · 2024 · 125 citations
Imetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase III study design
Review · Future Oncology · 2022 · 29 citations

FF
Faye Feller
10 papers
RK
Rami Komrokji
8 papers
Amer Zeidan
7 papers
Michael Savona
7 papers
Mikkael Sekeres
7 papers
Yazan Madanat
7 papers
SN
Shyamala Navada
6 papers
Peter Morcos
4 papers
Azra Raza
2 papers
SV
Srdan Verstovsek
2 papers
AG
Ajeet Gajra
1 paper
CB
Carrie Brownstein
1 paper